SCHEMBL18073582

SCHEMBL18073582

Cc1cc([Si](C)(C)C)cnc1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.44
▸ KDM4E B2RXH2 5/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ DHODH Q02127 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CKS1B P61024 1/20 0.40
▸ SKP1 P63208 1/20 0.40
▸ SKP2 Q13309 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ PTGS1 P23219 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205844 0.79 PSMB5 (0.51) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL2479064 0.79 PDE10A (0.48) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL18606213 0.77 PSMB5 (0.50) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL18136474 0.76 DYRK1B (0.46) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL2406888 0.76 PDK1 (0.46) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL18136473 0.76 DHODH (0.48) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL18573273 0.76 ESR2 (0.48) PDE10AKDM4ESMN1; SMN2HPGDDHODH
SCHEMBL22168548 0.74 PSMB5 (0.41) KDM4ESMN1; SMN2HPGDALDH1A1RAB9A
SCHEMBL29540461 0.74 SGK1 (0.34) PDE10ASMN1; SMN2CKS1BSKP1SKP2
SCHEMBL24066439 0.73 NPC1 (0.46) PDE10AKDM4ESMN1; SMN2HPGDDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11672167-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-06-06 — — US disclosed
US-11672167-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-06-06 — — US disclosed
US-20200212323-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 — — US disclosed
US-10629829-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-21 — — US disclosed
US-20160268522-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-09-15 — — US disclosed
US-20160268522-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-09-15 — — US disclosed
EP-3067360-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10629829-B2 Organometallic compound and organic light-emitting device including the same CRY1, CYC1, CYBA PDE10A 4414/4885KDM4E 2672/4885SMN1; SMN2 3469/4885
US-20160268522-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYC1, CYBA PDE10A 4414/4885KDM4E 2672/4885SMN1; SMN2 3469/4885
US-20200212323-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYC1, CYBA PDE10A 4414/4885KDM4E 2672/4885SMN1; SMN2 3469/4885
US-11672167-B2 Organometallic compound and organic light-emitting device including the same CRY1, CYC1, CYBA PDE10A 4414/4885KDM4E 2672/4885SMN1; SMN2 3469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback